All posts tagged
More News! Is CRISPR better than TALEN for CAR-T?
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy gets ready for Clinical Trials
Novartis Relies on Biotech to keep up its Solid Financial Performance
10 Hot European Biotechs to Observe in 2017 🚀
The 8 Biggest Biotech Medical Fails of 2016 in Europe
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
These are our 10 Most Read Biotech Articles of 2016
Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis
What do the CAR-T Patient Deaths Mean for the Future of the Field?
How is European Immuno-Oncology fighting Blood Cancer?
Celyad’s Autologous CAR-T Therapy enters Phase Ib
UPDATE: Future of CAR-T shaken by Novartis R&D Shuffle
Labiotech UG, All Rights Reserved -
Send this to friend